BERNADETTE SERAFINI: Open Payments
NPI 1497398606 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,044 in 31 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,044
Food & beverage: $1,044
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $323 |
| E.R. Squibb & Sons, L.L.C. | 5 | $178 |
| Janssen Pharmaceuticals, Inc | 4 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $122 |
| Indivior Inc. | 2 | $76 |
| ABBVIE INC. | 3 | $71 |
| Braeburn Inc. | 2 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: ARISTADA, COBENFY, INVEGA SUSTENNA, LYBALVI, CAPLYTA, SUBLOCADE, VRAYLAR, BRIXADI.
Industry payments across FL — which companies pay providers there.
